Project Grant HT94252411036
Award Date
9/15/24
Completion Date
9/14/26
Dollars Obligated
$360K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
This federal Project Grant award, totaling $1,012,894.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to investigate pain reprocessing therapy for veterans with chronic back pain. The 4-year award, with a start date of September 30, 2024, will compare the efficacy of this therapy and examine facilitators and barriers to implementation. The University of Colorado-Denver is the prime awardee, with sub-awards going to Texas...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will provide $332,716.00 to Michigan State University to assess the feasibility of implementing manual medicine techniques in the multimodal management of chronic low back pain among veterans and service members. The research, which will be conducted from November 1, 2024, to October 31, 2026, aims to explore innovative approaches to...
The $890,826 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will support a study by the Denver Research Institute (DRI) to evaluate the comparative efficacy and implementation factors of Pain Reprocessing Therapy for veterans with chronic back pain. The four-year project, starting on September 30, 2024, will conduct research to assess the clinical effectiveness of this novel pain management approach and...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,844,306.00 Project Grant to the Regents of the University of Michigan on September 1, 2025. The grant, titled "COTARGETING NSD1/2 PARALOGS IN AR-DRIVEN CASTRATION-RESISTANT PROSTATE CANCER," will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will investigate innovative medical...
The Defense Health Agency awarded a $553,588 Project Grant to Michigan State University on September 1, 2023 to conduct research on "NEUROBIOLOGICAL MECHANISMS TO ALLEVIATE COMORBID PAIN AND OBESITY." This Project Grant is funded through the Military Medical Research and Development program (CFDA 12.420) which supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public. As the prime awardee, Michigan State University...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $1,100,747.00 to the Regents of the University of Michigan to conduct research on "PROTEIN ENGINEERING OF ANTIBODY-DRUG CONJUGATES TO COORDINATE THE INNATE AND ADAPTIVE IMMUNE SYSTEMS FOR CURATIVE RESPONSES." The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical...
The Regents of the University of Michigan received a $312,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The 2-year grant, awarded on February 1, 2024, supports research to investigate "An Unexpected Role for the Ubiquitin Proteasome System in Repeat Associated Non-AUG Translation." This basic and translational biomedical research aims to advance understanding and treatment of neurological disorders...
The federal Project Grant award of $2,477,715.00 from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to the Regents of the University of Michigan supports research to develop an exoskeleton control system using a muscle cuff regenerative peripheral nerve interface (MC-RPNI) for restoring lower limb function following traumatic musculoskeletal injury. The project aims to transform healthcare for military service members, veterans, and the broader public...
The Defense Health Agency awarded a $1,178,939.00 Project Grant to the Regents of the University of Michigan under the Military Medical Research and Development program (CFDA 12.420) to conduct advanced phenotyping research to improve diagnostic, longitudinal assessment, and treatment strategies for deployment-related respiratory disease. The award period is from September 1, 2023 to August 31, 2026. As a U.S. Government Entity and top public research university, the University of Michigan has...
The federal Project Grant award of $624,000.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program supports research at the University of Michigan to investigate the role of epithelial AIM2 in Helicobacter pylori-associated gastric preneoplasia. The award, effective from July 15, 2025 to July 14, 2027, will fund advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public....